[Mechanism of Butylphthalide in Treating Delayed Encephalopathy After Carbon Monoxide Poisoning Based on Activation

Yu Shi1, Bao-Jun Wang2, Chao Chen2

  • 1Central Clinical Medical College of Baotou Medical College,Inner Mongolia University of Science and Technology,Baotou,Nei Mongol 014040,China.

Insights

Butylphthalide (NBP) treatment in mice with delayed encephalopathy after carbon monoxide poisoning (DEACMP) reduced microglia activation and inflammatory cytokine levels. This intervention improved cognitive function and mitigated brain tissue damage.

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Context:

  • Delayed encephalopathy after carbon monoxide poisoning (DEACMP) is a debilitating neurological condition.
  • Microglia activation and neuroinflammation are key pathological features of DEACMP.
  • Understanding the therapeutic mechanisms for DEACMP is crucial for developing effective treatments.

Purpose:

  • To investigate the mechanism by which butylphthalide (NBP) regulates microglia activation in a mouse model of DEACMP.
  • To assess the effect of NBP on inflammatory cytokine expression in the hippocampus of DEACMP mice.
  • To evaluate the impact of NBP on cognitive function and hippocampal injury in DEACMP.

Summary:

  • Butylphthalide (NBP) administration in DEACMP mice significantly reduced escape latency and increased nerve cell counts compared to the DEACMP group.
  • NBP treatment downregulated the expression and activation of ionized calcium-binding adapter molecule 1 (IBA1) in the hippocampus.
  • NBP effectively lowered the levels of pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β).

Impact:

  • NBP demonstrates neuroprotective effects by inhibiting microglia activation and reducing neuroinflammation.
  • The findings suggest that NBP can alleviate cognitive dysfunction and brain tissue damage associated with DEACMP.
  • NBP holds potential as a therapeutic agent for managing DEACMP and related neurological disorders.